Conversion of α-Cells to β-Cells in the Postpartum Mouse Pancreas Involves Lgr5 Progeny.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33906911.
- Also identified by DOI 10.2337/db20-1059 and PMC identifier 8336010.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In contrast to the skin and the gut, where somatic stem cells and their niche are well characterized, a definitive pancreatic multipotent cell population in the adult pancreas has yet to be revealed. Of particular interest is whether such cells may be endogenous in patients with diabetes, and if so, can they be used for therapeutic purposes? In the current study, we used two separate reporter lines to target Cre-recombinase expression to the Lgr5- or glucagon-expressing cells in the pancreas. We provide evidence for the existence of a population of cells within and in the proximity of the ducts that transiently express the stem-cell marker Lgr5 during late gestational stages. Careful timing of tamoxifen treatment in <i>Lgr5<sup>EGFP-IRES-CreERT2</sup></i> ;R26 <i><sup>Tomato</sup></i> mice allowed us to show that these <i>Lgr5</i>-expressing progenitor cells can differentiate into α-cells during pregnancy. Furthermore, we report on a spontaneous lineage conversion of α- to β-cells specifically after parturition. The contribution of Lgr5 progeny to the β-cell compartment through an α-cell intermediate phase early after pregnancy appears to be part of a novel mechanism that would counterbalance against excessive β-cell mass reduction during β-cell involution.
Medical subject headings
- Cell Lineage
- Glucagon-Secreting Cells
- Insulin-Secreting Cells
- Pancreas
- Postpartum Period
- Receptors, G-Protein-Coupled
- Stem Cells